Atlas Trials

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Clinical trial NCT05292443 · WITHDRAWN

Trial details

NCT number
NCT05292443
Sponsor
Geneplus-Beijing Co. Ltd.
Status
WITHDRAWN
Study type
OBSERVATIONAL
Primary Liver CancerHepatocellular CarcinomaIntrahepatic CholangiocarcinomaCombined Hepatocellular-cholangiocarcinoma
Start date
2021-12-20
Primary completion
2023-03-17
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.